This website uses cookies. By using this website, you agree to our Cookie Policy.
October 02, 2020
Intellectual Property special counsel Danielle Tully shares her insights on lawmakers’ interest in how pharmaceutical patents impact drug prices, and comments on the potential benefits of one legislative proposal.
